Q32 Bio
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -121 | -123 | ||
EBITDA | 6,709 | -18,691 | -17,798 | -14,720 |
EBIT | 6,589 | -18,814 | -17,919 | -14,843 |
Net Income | -14,189 | -17,595 | -16,978 | 1,029 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -11,430 | -19,580 | -22,229 | -14,551 |
Cash | 77,965 | 89,078 | 97,661 | 115,509 |
Basic Shares | 12,076 | 12,076 | 11,964 | 3,206 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1,156 | $6,651 | $33,971 |
Gross Profit | 578 | 4,052 | 24,427 | |
EBITDA | -86,502 | -38,855 | -86,220 | |
EBIT | -87,080 | -41,454 | -95,764 | |
Net Income | -47,733 | -112,961 | -42,809 | -37,564 |
Net Change In Cash | 0 | 1,156 | 6,651 | 33,971 |
Free Cash Flow | -67,790 | -96,458 | -13,442 | -33,136 |
Cash | 77,965 | 39,266 | 43,893 | 32,247 |
Basic Shares | 12,138 | 11,929 | 3,188 | 3,071 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$1.16 |
2024-09-30 | -$1.45 |
2024-06-30 | -$1.42 |
2024-03-31 | -$14.95 |
